Literature DB >> 13680361

Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis.

Moises Selman1, Hung-Mo Lin, Martha Montaño, Audrey L Jenkins, Andrea Estrada, Zhenwu Lin, Guirong Wang, Susan L DiAngelo, Xiaoxuan Guo, Todd M Umstead, C Max Lang, Annie Pardo, David S Phelps, Joanna Floros.   

Abstract

Derangement in pulmonary surfactant or its components and alveolar collapse are common findings in idiopathic pulmonary fibrosis (IPF). Surfactant proteins play important roles in innate host defense and normal function of the lung. We examined associations between IPF and genetic polymorphic variants of surfactant proteins, SP-A1, SP-A2, SP-B, SP-C, and SP-D. One SP-A1 (6A(4)) allele and single nucleotide polymorphisms (SNPs) that characterize the 6A(4) allele, and one SP-B (B1580_C) were found with higher frequency ( P</=0.01) in nonsmoker and smoker IPF ( n=84) subgroups, respectively, compared with healthy controls ( n=194). To explore whether a tryptophan (present in 6A(4)) or an arginine (present in other SP-A1 alleles and in all SP-A2 alleles) at amino acid 219 alters protein behavior, two truncated proteins that varied only at amino acid 219 were oxidized by exposure to ozone. Differences in the absorption spectra (310-350 nm) between the two truncated recombinant SP-A proteins were observed both before and after protein oxidation, suggesting allele-specific aggregation differences attributable to amino acid 219. The SP-B SNP B1580_C (odds ratio:7.63; confidence interval:1.64-35.4; P</=0.01), to be a risk factor for IPF smokers, has also been shown to be a risk factor for other pulmonary diseases. The SP-C and SP-D SNPs and SP-B-linked microsatellite markers studied did not associate with IPF. These findings indicate that surfactant protein variants may serve as markers to identify subgroups of patients at risk, and we speculate that these contribute to IPF pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13680361     DOI: 10.1007/s00439-003-1015-4

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  64 in total

1.  Treatment of idiopathic pulmonary fibrosis: the rise and fall of corticosteroids.

Authors:  H R Collard; T E King
Journal:  Am J Med       Date:  2001-03       Impact factor: 4.965

2.  TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment?

Authors:  M Selman; V Ruiz; S Cabrera; L Segura; R Ramírez; R Barrios; A Pardo
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-09       Impact factor: 5.464

Review 3.  Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification.

Authors:  A L Katzenstein; J L Myers
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

4.  Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis.

Authors:  A Günther; R Schmidt; F Nix; M Yabut-Perez; C Guth; S Rosseau; C Siebert; F Grimminger; H Morr; H G Velcovsky; W Seeger
Journal:  Eur Respir J       Date:  1999-09       Impact factor: 16.671

5.  MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If.

Authors:  B Schenk; T Imbach; C G Frank; C E Grubenmann; G V Raymond; H Hurvitz; I Korn-Lubetzki; S Revel-Vik; A Raas-Rotschild; A S Luder; J Jaeken; E G Berger; G Matthijs; T Hennet; M Aebi
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

6.  Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis.

Authors:  Beata Hutyrová; Panagiotis Pantelidis; Jirí Drábek; Monika Zůrková; Vítezslav Kolek; Karel Lenhart; Kenneth I Welsh; Roland M Du Bois; Martin Petrek
Journal:  Am J Respir Crit Care Med       Date:  2002-01-15       Impact factor: 21.405

Review 7.  Surfactant regulation of host defense function in the lung: a question of balance.

Authors:  D S Phelps
Journal:  Pediatr Pathol Mol Med       Date:  2001 Jul-Aug

8.  Decreased lung compliance and air trapping in heterozygous SP-B-deficient mice.

Authors:  J C Clark; T E Weaver; H S Iwamoto; M Ikegami; A H Jobe; W M Hull; J A Whitsett
Journal:  Am J Respir Cell Mol Biol       Date:  1997-01       Impact factor: 6.914

9.  Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis.

Authors:  K E Greene; T E King; Y Kuroki; B Bucher-Bartelson; G W Hunninghake; L S Newman; H Nagae; R J Mason
Journal:  Eur Respir J       Date:  2002-03       Impact factor: 16.671

10.  Surfactant protein A increases matrix metalloproteinase-9 production by THP-1 cells.

Authors:  Luis G Vazquez de Lara; Todd M Umstead; Sara E Davis; David S Phelps
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-07-03       Impact factor: 5.464

View more
  71 in total

1.  Differential effects of human SP-A1 and SP-A2 variants on phospholipid monolayers containing surfactant protein B.

Authors:  Guirong Wang; Svetla Taneva; Kevin M W Keough; Joanna Floros
Journal:  Biochim Biophys Acta       Date:  2007-07-06

2.  Surfactant protein A2 (SP-A2) variants expressed in CHO cells stimulate phagocytosis of Pseudomonas aeruginosa more than do SP-A1 variants.

Authors:  Anatoly N Mikerov; Guirong Wang; Todd M Umstead; Mario Zacharatos; Neal J Thomas; David S Phelps; Joanna Floros
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

Review 3.  Genetic predisposition to respiratory diseases: infiltrative lung diseases.

Authors:  Mark P Steele; Kevin K Brown
Journal:  Respiration       Date:  2007       Impact factor: 3.580

4.  Angiotensin-converting enzyme (ACE) gene polymorphisms are associated with idiopathic pulmonary fibrosis.

Authors:  Soo-Taek Uh; Tae-Hoon Kim; Eun-Young Shim; An-Soo Jang; Sung-Woo Park; Jong-Sook Park; Byung-Lae Park; Byoung Whui Choi; Hyoung Doo Shin; Dong Soon Kim; Choon-Sik Park
Journal:  Lung       Date:  2013-05-09       Impact factor: 2.584

5.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

Review 6.  Is Progression of Pulmonary Fibrosis due to Ventilation-induced Lung Injury?

Authors:  Richard K Albert; Bradford Smith; Carrie E Perlman; David A Schwartz
Journal:  Am J Respir Crit Care Med       Date:  2019-07-15       Impact factor: 21.405

Review 7.  The genetic approach in pulmonary fibrosis: can it provide clues to this complex disease?

Authors:  William E Lawson; James E Loyd
Journal:  Proc Am Thorac Soc       Date:  2006-06

Review 8.  Pulmonary Fibrosis in Hermansky-Pudlak Syndrome.

Authors:  Glenn W Vicary; Yeidyly Vergne; Alberto Santiago-Cornier; Lisa R Young; Jesse Roman
Journal:  Ann Am Thorac Soc       Date:  2016-10

9.  Impact of ozone exposure on the phagocytic activity of human surfactant protein A (SP-A) and SP-A variants.

Authors:  Anatoly N Mikerov; Todd M Umstead; Xiaozhuang Gan; Weixiong Huang; Xiaoxuan Guo; Guirong Wang; David S Phelps; Joanna Floros
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-11-02       Impact factor: 5.464

10.  Association of FcγRIIa R131H polymorphism with idiopathic pulmonary fibrosis severity and progression.

Authors:  Stylianos Bournazos; Jacob Grinfeld; Karen M Alexander; John T Murchison; William A Wallace; Pauline McFarlane; Nikhil Hirani; A John Simpson; Ian Dransfield; Simon P Hart
Journal:  BMC Pulm Med       Date:  2010-10-07       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.